Key result
Extended biventricular assist device support for 12 months in a patient with giant cell myocarditis resulted in extensive fibrosis but no evidence of active disease in the explanted heart.
Population
1 Asian woman with giant cell myocarditis presenting with palpitations, syncope, and rapidly deteriorating…
Design
Case_report
Follow-up
12 months
Authors
Loading...
Supports hypothesis of BiVAD as immunosuppression-free bridge in giant cell myocarditis; leaves open need for prospective validation before practice change.
Case Report (n=1)
Extended BiVAD support without immunosuppression may allow for the resolution of active giant cell myocarditis prior to heart transplantation.
Eid et al. (2009) conducted a case report in Giant cell myocarditis (n=1). Biventricular assist device (BiVAD) implantation was evaluated on Evidence of active giant cell myocarditis in the heart explant. Extended biventricular assist device support for 12 months in a patient with giant cell myocarditis resulted in extensive fibrosis but no evidence of active disease in the explanted heart.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: